| 1 |
32313135 | Pharmacological and genetic targeting of 5-lipoxygenase interrupts c-Myc oncogenic signaling and kills enzalutamide-resistant prostate cancer cells via apoptosis. | 2020 Apr 20 |
2 |
| 2 |
30728896 | Inhibition of 5-lipoxygenase downregulates stemness and kills prostate cancer stem cells by triggering apoptosis via activation of c-Jun N-terminal kinase. | 2019 Jan 11 |
3 |
| 3 |
25540201 | Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer cells. | 2015 Feb 20 |
2 |
| 4 |
21824498 | Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon. | 2011 Dec |
2 |
| 5 |
19906484 | MK591, a leukotriene biosynthesis inhibitor, induces apoptosis in prostate cancer cells: synergistic action with LY294002, an inhibitor of phosphatidylinositol 3'-kinase. | 2010 May 28 |
1 |
| 6 |
10531413 | Activation of leukotriene synthesis in human neutrophils by exogenous arachidonic acid: inhibition by adenosine A(2a) receptor agonists and crucial role of autocrine activation by leukotriene B(4). | 1999 Nov |
1 |
| 7 |
9507210 | Regulatory interactions between inducible nitric oxide synthase and eicosanoids in glomerular immune injury. | 1998 Mar |
1 |
| 8 |
9041233 | Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591. | 1997 Mar |
1 |
| 9 |
7697951 | Blockade of leukotriene production by a single oral dose of MK-0591 in active ulcerative colitis. | 1995 Mar |
2 |
| 10 |
7822663 | The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. | 1995 Jan |
2 |
| 11 |
8033491 | Pharmacokinetics and pharmacodynamics of multiple oral doses of MK-0591, a 5-lipoxygenase-activating protein inhibitor. | 1994 Jul |
1 |